Biodexa Pharmaceuticals Plc (BDRX) stock
BDRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 27, 2026Score 1/30
$2.24−0.16 (-6.67%)
Close on Nov 16, 2026Market cap $5.06MP/E –Yield –
Biodexa Pharmaceuticals operating margin
Operating margin is operating income as a percentage of revenue.
For fiscal 2023 it was -2103.4%, against -1277.8% the year before. The highest annual figure on record is -609.6% in fiscal 2018.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -2103.4% | −825.6 |
| FY2022 | Dec 31, 2022 | -1277.8% | −67.1 |
| FY2021 | Dec 31, 2021 | -1210.7% | +5506.5 |
| FY2020 | Dec 31, 2020 | -6717.2% | −5038.0 |
| FY2019 | Dec 31, 2019 | -1679.2% | −1069.6 |
| FY2018 | Dec 31, 2018 | -609.6% | +732.7 |
| FY2017 | Dec 31, 2017 | -1342.4% | −612.8 |
| FY2016 | Dec 31, 2016 | -729.6% | +209.9 |
| FY2015 | Dec 31, 2015 | -939.5% | – |
See a number that looks wrong?